Tocilizumab efficacy in a patient with positive anti-CCP chronic Lyme arthritis

被引：1
|
作者：
Hirsch, Julianna [1 ]
Rosner, Itzhak [1 ,2 ]
Rimar, Doron [1 ,2 ]
Kaly, Lisa [1 ,2 ]
Rozenbaum, Michael [1 ,2 ]
Boulman, Nina [1 ,2 ]
Slobodin, Gleb [1 ,3 ]
机构：
[1] Technion Israel Inst Technol, Dept Med, Haifa, Israel
[2] Bnai Zion Med Ctr, Dept Rheumatol, Haifa, Israel
[3] Bnai Zion Med Ctr, Dept Internal Med A, Haifa, Israel
来源：
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES | 2016年 / 8卷 / 04期
关键词：
Lyme arthritis; lyme disease; tocilizumab;
D O I：
10.4103/1947-2714.179960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Context: Lyme arthritis, a manifestation of tick-borne Lyme disease, can prove to be refractory to classic treatment. Case Report: We present a case of a 48-year-old male, diagnosed with chronic Lyme arthritis, refractory to recurrent and prolonged courses of doxycycline, ceftriaxone, as well as hydroxychloroquine and methotrexate. The patient responded partially to tumor necrosis factor (TNF)-alpha blockade by etanercept and, finally, entered long-term remission after his treatment was switched to tocilizumab. Conclusion: Off label treatment by biologic disease modifying antirheumatic drugs can be considered in selected patients with severe antibiotic-resistant Lyme arthritis.C.
引用
收藏
页码：194 / 196
页数：3
相关论文
共 50 条
  • [1] Efficacy of Anti-CCP in Rheumatoid arthritis
    Tolga, Seyma
    Ozgonenel, Levent
    Tutun, Sule
    ISTANBUL MEDICAL JOURNAL, 2006, 7 (02): : 21 - 23
  • [2] Anti-CCP biosensors in rheumatoid arthritis
    Karami, Pari
    Gholamin, Danial
    Fathi, Farzaneh
    Afsar, Taha
    Johari-Ahar, Mohammad
    CLINICA CHIMICA ACTA, 2024, 561
  • [3] Does a positive anti-CCP test identify a distinct arthritis entity?
    Thomas Skogh
    Arthritis Research & Therapy, 7
  • [4] Does a positive anti-CCP test identify a distinct arthritis entity?
    Skogh, T
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (06) : 230 - 232
  • [5] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
    N. Inanc
    E. Dalkılıc
    S. Kamalı
    E. Kasapoglu-Günal
    Y. Elbir
    H. Direskeneli
    M. Inanc
    Clinical Rheumatology, 2007, 26 : 17 - 23
  • [6] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
    Inanc, N.
    Dalkilic, E.
    Kamali, S.
    Kasapoglu-Gunal, E.
    Elbir, Y.
    Direskeneli, H.
    Inanc, M.
    CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 17 - 23
  • [7] Synovial differences between anti-CCP positive
    van Oosterhout, M.
    Bajema, I. M.
    Levarht, N. W. N.
    Toes, R. E. M.
    Huizinga, T. W. J.
    van Laar, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 82 - 82
  • [8] Smoking is associated with occurrence of anti-CCP antibodies and is a risk factor only for anti-CCP antibody positive RA
    Padyukov, L
    Ronnelid, J
    Stolt, R
    Alfredsson, L
    Klareskog, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 164 - 164
  • [9] The Complexity of Anti-CCP Positive Rheumatoid Arthritis, in the Context of Gene-Environment Associations
    Lundberg, Karin
    Bengtsson, Camilla
    Israelsson, Lena
    Kharlamova, Nastya
    Pollak-Dorocic, Iskra
    Holmdahl, Rikard
    Padyukov, Leonid
    Malmstrom, Vivianne
    Alfredsson, Lars
    Klareskog, Lars
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S842 - S842
  • [10] Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis
    Cheng, Zijian
    Thuy Do
    Mankia, Kulveer
    Meade, Josephine
    Hunt, Laura
    Clerehugh, Val
    Speirs, Alastair
    Tugnait, Aradhna
    Emery, Paul
    Devine, Deirdre
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 162 - 168
12345